PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- First Posted Date
- 2011-08-12
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10497
- Registration Number
- NCT01416194
A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372.
- Conditions
- Phase 1Single DoseSafetyTolerationPharmacokinetics
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2011-08-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT01415102
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2860
- Registration Number
- NCT01414257
- Locations
- 🇯🇵
University of Occupational and Environmental Health Hospital, Kitakyushu-shi, Fukuoka-ken, Japan
A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 15
- Registration Number
- NCT01411228
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
🇿🇦Morningside Medi-Clinic, Morningside, South Africa
🇵🇾Instituto Privado de Hematologia E Investigacion Clinica (I.P.H.I.C), Barrio Asuncion, Paraguay
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 160
- Registration Number
- NCT01411215
- Locations
- 🇨🇳
No. 199, Haerbin, Heilongjiang, China
🇨🇳The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China
🇨🇳The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 5
- Registration Number
- NCT01408355
- Locations
- 🇬🇧
Pfizer Investigational Site, Ruddington Fields, Nottingham, United Kingdom
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2011-09-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6
- Registration Number
- NCT01407016
- Locations
- 🇯🇵
Pfizer Investigational Site, Tokyo, Japan
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
- Conditions
- Lupus Erythematosus, Systemic
- Interventions
- Biological: PF-04236921
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2017-12-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 183
- Registration Number
- NCT01405196
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Pinnacle Research Group, LLC, Anniston, Alabama, United States
🇺🇸Anniston Medical Clinic, PC, Anniston, Alabama, United States
A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2018-10-30
- Lead Sponsor
- Pfizer
- Registration Number
- NCT01405170
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2018-10-30
- Lead Sponsor
- Pfizer
- Registration Number
- NCT01405131